PHARMACYTE BIOTECH

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box®. This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. PharmaCyte Biotech’s treatment for pancreatic... cancer involves low doses of the well-known anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or “cancer-killing” form. These capsules are placed as close to the cancerous tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. This “targeted chemotherapy” has proven remarkably effective in past clinical trials. In addition, PharmaCyte Biotech is working towards improving the quality of life for patients with advanced pancreatic cancer and on treatments for other types of solid cancerous tumors. PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of marijuana known as cannabinoids. In doing so, PharmaCyte Biotech is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. This provides PharmaCyte Biotech the rare opportunity to develop “green” approaches to fighting deadly cancers, such as those of the pancreas, brain and breast, which affect hundreds of thousands of individuals worldwide every year.
PHARMACYTE BIOTECH
Industry:
Biotechnology Clinical Trials Health Care Medical Medical Device
Founded:
1996-01-01
Address:
Laguna Hills, California, United States
Country:
United States
Website Url:
http://www.pharmacytebiotech.com
Total Employee:
11+
Status:
Active
Contact:
(917)595-2850
Email Addresses:
[email protected]
Total Funding:
87.14 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator Amazon California Region
Similar Organizations
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Senseonics
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2011-07-21 | PharmaCyte Biotech | PharmaCyte Biotech acquired by PharmaCyte Biotech | N/A |
Key Employee Changes
Date | New article |
---|---|
2020-08-10 | PharmaCyte Biotech Appoints Dr. José Iglesias as Consulting Chief Medical Officer for Clinical Trial in Pancreatic Cancer |
Official Site Inspections
http://www.pharmacytebiotech.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109

More informations about "PharmaCyte Biotech"
PharmaCyte Biotech, Inc. (PMCB)
May 21, 2024 PharmaCyte Biotech, Inc. 3960 Howard Hughes Parkway, Suite 500 Las Vegas, Nevada 89169 Office Number: 917.595.2850 Facsimile Number: 917.595.2851 Email: …See details»
PharmaCyte Biotech, Inc. | PharmaCyte Biotech is a …
PharmaCyte Biotech Inc. 3960 Howard Hughes Parkway, Suite 500 Las Vegas, Nevada 89169 Office Number: 917.595.2850 Facsimile Number: 917.595.2851 Email: [email protected] Latest News. PharmaCyte Biotech Board of Directors …See details»
PharmaCyte Biotech - Crunchbase Company Profile & Funding
PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of marijuana known as cannabinoids. In doing so, PharmaCyte Biotech is examining ways to …See details»
PharmaCyteBiotech
PharmaCyteBiotechSee details»
PharmaCyte Biotech, Inc. | Company
Aug 15, 2022 PharmaCyte Biotech Inc. 3960 Howard Hughes Parkway, Suite 500 Las Vegas, Nevada 89169 Office Number: 917.595.2850 Facsimile Number: 917.595.2851 Email: [email …See details»
PharmaCyte Biotech, Inc. (PMCB) - Yahoo Finance
See the company profile for PharmaCyte Biotech, Inc. (PMCB) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
PharmaCyte Biotech - LinkedIn
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary …See details»
PharmaCyte Biotech Company Profile - Office Locations ... - Craft
Oct 4, 2024 PharmaCyte Biotech is a clinical-stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes. It uses its …See details»
PharmaCyte Biotech, Inc. - AnnualReports.com
PharmaCyte Biotech, Inc. Most Recent Annual Report. MOST RECENT 2023 Annual Report and Form 10K. View PDF View Form 10K (HTML) Older/Archived Annual Reports. 2022 Annual Report View Annual Report Download. 2021 …See details»
PharmaCyte Biotech, Inc. - Prism MarketView
Jan 2, 2024 PharmaCyte Biotech, Inc. 3960 Howard Hughes Parkway Suite 500 Las Vegas, NV 89169 United States. 917 595 2850; https://pharmacyte.com; [email protected]; PharmaCyte Biotech is a clinical stage biotechnology …See details»
PharmaCyte Biotech, Inc. | Las Vegas NV - Facebook
PharmaCyte Biotech, Inc., Las Vegas, Nevada. 1,537 likes · 1 was here. PharmaCyte Biotech (NASDAQ: PMCB) is a clinical stage biotechnology company focused on developing targeted treatments for cancer...See details»
PharmaCyte Biotech Announces Launch of New Corporate Website
PharmaCyte Biotech’s new website is the latest step in a transformation process to brand PharmaCyte Biotech as solely a biotechnology firm. With the recent name and ticker symbol …See details»
PharmaCyte Biotech, Inc. (PMCB) - Yahoo Finance
Find the latest PharmaCyte Biotech, Inc. (PMCB) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
PharmaCyte Biotech - Overview, News & Similar companies
May 20, 2024 Who is PharmaCyte Biotech. PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and …See details»
PharmaCyte Biotech, Inc. (PMCB) - Stock Analysis
2 days ago About PMCB. PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are …See details»
PharmaCyte Biotech - Contacts, Employees, Board Members
Organization. PharmaCyte Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Number of Board Member and Advisor Profiles 8. Contacts 1. …See details»
PharmaCyte Biotech - Funding, Financials, Valuation & Investors
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer. Search Crunchbase. ... How much funding …See details»
PharmaCyte Biotech: A Balanced Look (NASDAQ:PMCB)
Jan 12, 2015 PharmaCyte Biotech (OTCQB:PMCB) (Formally Nuvilex) is a quite curious company. The company is engaged, along with its subsidiaries, in the biotech field and the …See details»
PharmaCyte Biotech, Inc. | PharmaCyte Biotech Releases More …
Sep 21, 2021 PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests. 21 SEP 21 ... The study, which was performed by a third-party Contract …See details»
PharmaCyte forced to think outside the box as CEO departs amid …
Oct 7, 2022 Pharmacyte Biotech FDA Chutes and Ladders clinical hold Long-time PharmaCyte CEO Kenneth Waggoner has departed the biotech, leaving amid a cost freeze on all programs …See details»